Questions? Let’s Chat
Our team can help you understand how to include proper at-home drug disposal in your prevention plan. Schedule a call today to learn more.
Our new grant guide is available! Get the updated edition for expert grant-writing help.
Opioid settlement funds are being distributed in all 50 states. View the status of your state’s funds.
Get the updated Deterra Grant Guide.
We’ll let you know when a key deadline is approaching.
New grant opportunities will be posted here.
Grants and opioid settlements can provide critical funding for prevention efforts, but understanding how to secure these funds can be an intimidating process.
Below, you’ll find links to funding sources that other organizations have had success in using to purchase and distribute evidence-based prevention solutions like the Deterra® Drug Deactivation and Disposal System.
This funding page will be updated regularly as additional funding opportunities are released throughout the year. Check this page periodically for updates and join our email list to receive an email alert when a new grant opportunity is posted.
The funding opportunities listed below are not an exhaustive list and funding is not guaranteed to be available.
Arkansas expects to receive $216 million in settlement funds over 18 years. Funds will be divided evenly with one-third allocated to cities, one-third to counties, and one-third to the state. Eligible entities can apply for grant funding through the Arkansas Opioid Recovery Partnership (ARORP).
The Illinois Remediation Fund will receive 55% of the settlement proceeds and will be administered by the Illinois Department of Human Services (IDHS) for activities that address the opioid crisis throughout Illinois. The other 45% of the settlement funds will be distributed between the state, counties, and local governments.
A portion of settlement funds is allocated to local counties. An estimate of settlement allocations by county is available from the Kentucky Association of Counties.
In addition, the state’s portion of the settlement funds is administered by the Kentucky Opioid Abatement Advisory Commission (OAAC). Grant funding from the OAAC is available for eligible organizations and government agencies.
Tennessee’s Opioid Abatement Council (OAC) has allocated initial payments from opioid lawsuit settlements to counties totaling more than $31.4 million.
The OAC is accepting applications for its community grants through Oct. 9.
Virginia is expected to receive $734 million in national settlement funds. Funds have been allocated to Virginia counties and cities. In addition, Virginia’s Opioid Abatement Authority is accepting grant applications for financial assistance to cities, counties, and state agencies through its Grants Portal.
Wisconsin anticipates more than $400 million in total funding. The Wisconsin Department of Health Services will receive 30% of the allotted funds and the remaining 70% will be allocated to local counties and cities.
$26 billion from multidistrict litigation (MDL) settlement funds will be allocated to all 50 states at the state and county levels. In addition to the MDL funds, there are two other settlements that impact multiple states:
Deadline: Invitation Only
Eligibility: Grant programs at the AmerisourceBergen Foundation are all invitation-only.
Overview: The AmerisourceBergen Foundation collaborates with organizations to implement projects with the common objective of providing everyone, both humans and animals, with a fair and just opportunity to be as healthy as possible. Specific areas funded includes prescription drug safety to combat misuse in the U.S. through safe disposal and innovative solutions.
Award Range: up to $100,000
Number of Expected Awards: unknown
Deadline: Community Grant is by invitation only
Eligibility: Organizations must be invited to participate in the grant process, and are required to provide services in at least one of the following areas:
Overview: Giving strategy supports organizations and initiatives dedicated to:
Number of Expected Awards: unknown
The American Rescue Plan will deliver $350 billion for eligible state, local, territorial and tribal governments to respond to the Covid-19 emergency. Funds can address systemic public health and economic challenges that have contributed to the unequal impact of the pandemic. This includes:
The purpose of this program is to address the opioid overdose crisis by providing resources to states and territories for increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and for supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and other concurrent substance use disorders. The SOR program also supports the continuum of care for stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR program aims to help reduce unmet treatment needs and opioid-related overdose deaths across America. Eligibility was limited to Single State Agencies and territories.
The purpose of the TOR program is to assist in addressing the overdose crisis in Tribal communities by increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and co-occurring substance use disorders. The TOR program also supports the full continuum of prevention, harm reduction, treatment and recovery support services for stimulant misuse and use disorders, including for cocaine and methamphetamine. Eligibility is limited to federally recognized American Indian or Alaska Native Tribe or tribal organizations. Tribes and tribal organizations may apply individually, as a consortium, or in partnership with an Urban Indian Organizations.
The purpose of the SPF Rx grant program is to provide resources to help prevent and address prescription drug misuse within a State or locality. The program is designed to raise awareness about the dangers of sharing medications as well as the risks of fake or counterfeit pills purchased over social media or other unknown sources, and work with pharmaceutical and medical communities on the risks of overprescribing. Whether addressed at the state level or by an informed community-based organization, the SPF Rx program will raise community awareness and bring prescription substance misuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, grant recipients will be required to track reductions in opioid related overdoses and incorporate relevant prescription and overdose data into strategic planning and future programming. Eligible applicants were domestic public and private non-profit entities.
The purpose of the program is to support community-based overdose prevention programs, syringe services programs, and other harm reduction services. Funding will be used to enhance overdose and other types of prevention activities to help control the spread of infectious diseases and the consequences of such diseases for individuals with, or at risk of developing substance use disorders (SUD), support distribution of FDA-approved overdose reversal medication to individuals at risk of overdose, build connections for individuals at risk for, or with, a SUD to overdose education, counseling, and health education, refer individuals to treatment for infectious diseases such as HIV, sexually transmitted infections (STIS), and viral hepatitis, and encourage such individuals to take steps to reduce the negative personal and public health impacts of substance use or misuse. This will include supporting capacity development to strengthen harm reduction programs as part of the continuum of care. recipients will also establish processes, protocols, and mechanisms for referral to appropriate treatment and recovery support services. Grantees will also provide overdose prevention education to their target populations regarding the consumption of substances including but not limited to opioids and their synthetic analogs. Funds may also be used to purchase equipment and supplies to enhance harm reduction efforts, such as medication disposal kits. Eligible applicants were States; local, Tribal, and territorial governments; Tribal organizations; non-profit community-based organizations; and primary and behavioral health organizations.
Eligibility: All domestic public or private, non-profit, or for-profit entities, including community-based organizations, federally recognized tribes, tribal organizations, state, local and territorial governments, and institutions of higher education.
Geographic Focus: Rural-designated areas- Delivery of all services supported by RCORP-Overdose Response program must exclusively occur in HRSA-designated rural counties and rural census tracts, as defined by the Rural Health Grants Eligibility Analyzer. Within partially rural counties, services supported by this award may only be delivered within HRSA-designated rural census tracts, except as noted below. If applicants do not clearly describe an exclusively rural service area and/or list any non-HRSA-designated rural counties and census tracts, the application will be deemed non-responsive.
Overview: The purpose of this program is to support immediate responses to the overdose crisis in rural areas through improving access, to, capacity for, and sustainability of prevention, treatment, and recovery services for substance use disorder (SUD). Over the course of a one-year period of performance, RCORP-Overdose Response recipients will address immediate needs in rural areas through improving access to, capacity for, and sustainability of prevention, treatment and recovery services for substance use disorder (SUD).
Number of Expected Awards: 40
Award Range: Up to $300,000 per award
Overview: This program provides resources to support state, local, tribal, and territorial efforts to respond to substance use and misuse; reduce overdose deaths; promote public safety; and support access to prevention, harm reduction, treatment, and recovery services in the community and justice system.
Eligibility: Applicants may apply in one of two categories:
Category 1: Local Applicants.
City or township governments
Other city, township or county governments in rural areas
Federally recognized tribal governments
Category 2: State Applicants.
Units of state governments (ex. state alcohol and substance use agency)
Number of Expected Awards: 72
Urban area or large county: up to $1.6 million
Suburban area or medium-sized county: up to $1.3 million
Rural areas and tribal governments: up to $1 million
State agencies: up to $7 million
Overview: The purpose of the SPF-PFS program is to help reduce the onset and progression of substance misuse and its related problems by supporting the development and delivery of state and community substance misuse prevention and mental health promotion services.
Eligibility: U.S. States, U.S. Territories, Pacific Jurisdictions, and the District of Columbia
Number of Expected Awards: 14
Award Range: Up to $1.25 million per award
Fill out the form below to see best practices for writing a strong grant application.
“This was much easier than any other drug disposal system that I have ever used.”
“Deterra has brought me peace of mind that my medications are now safely inactivated and disposed of in an environmentally safe manner. They should come with every opioid prescription!”
“What a wonderful product! So easy and so convenient.”
To help you navigate the world of grant opportunities, we’ve put together a free guide with practical tips on how to secure funds for evidence-based prevention solutions like Deterra.
The new expanded edition of the Deterra Grant Guide is now available!
In this updated guide, you’ll find: